MetaCap

Centene (CNC) vs Labcorp (LH)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Centene (CNC) has outperformed Labcorp (LH) over the past year, gaining 74.7% versus a gain of 38.2%. Over five years, LH leads with a +47.7% price change compared with -13.7% for CNC. Centene is the larger company by market cap ($31.58 billion vs $29.81 billion), about 1.1 times the size.

On valuation, Centene trades at a lower forward P/E (11.4x vs 18.7x for Labcorp). Labcorp pays a dividend yielding 0.78%, while Centene does not currently pay one. Labcorp converts more of its revenue into profit, with a net margin of 6.3% versus -3.4%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CNC+74.74%LH+38.21%
+114%+48%-19%
Nov 21, 20251 yearNov 20, 2026
CNC-12.64%LH+50.83%
+58%-6%-71%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CNC versus LH key metrics
MetricCNCLH
Share price$63.78$367.13
Market cap$31.58B$29.81B
1-day change-2.74%-0.47%
YTD return+54.99%+46.34%
1-year return+74.74%+38.21%
5-year return-13.69%+47.71%
P/E ratio (TTM)21.9230.09
Forward P/E11.4518.73
EPS (TTM)$2.91$12.20
Dividend yield0.00%0.78%
Annual dividend$0.00$2.88
Revenue (latest FY)$194.78B$13.95B
Revenue growth (YoY)+19.44%+7.25%
Net income (latest FY)$-6.67B$876.50M
Gross margin7.30%28.76%
Operating margin-3.91%9.92%
Net margin-3.43%6.28%
52-week high$78.08$375.10
52-week low$31.63$245.00
Distance from 52-week high-18.31%-2.12%
Analyst consensusbuybuy
Avg. price target upside+19.33%+6.25%
Average volume5.09M744.44K
Shares outstanding495.07M81.20M
Employees61,10071,000
SectorHealth CareHealth Care
IndustryMedical SpecialitiesMedical Specialities

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • CNC has outperformed LH by 36.5 percentage points over the past year.
  • Labcorp trades at a higher earnings multiple (30.1x vs 21.9x trailing P/E).
  • Labcorp is more profitable, keeping 6.3 cents of every revenue dollar as net income versus -3.4 cents for Centene.
  • Centene grew revenue faster in its latest fiscal year (+19.44% vs +7.25%).

About Centene

CNC stock →

Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other.

Health Care · Medical Specialities · 61,100 employees

About Labcorp

LH stock →

Labcorp Holdings Inc. provides laboratory services.

Health Care · Medical Specialities · 71,000 employees

CNC vs LH FAQ

Which is bigger, Centene or Labcorp?

Centene (CNC) is larger, with a market capitalization of $31.58B compared with $29.81B for Labcorp (LH).

Which stock has performed better over the past year, CNC or LH?

CNC returned +74.74% over the past 12 months, compared with +38.21% for LH (price return, excluding dividends). Past performance does not predict future results.

Which has the lower P/E ratio, CNC or LH?

CNC has the lower trailing P/E at 21.9, versus 30.1 for LH. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.

Which pays a higher dividend, Centene or Labcorp?

Labcorp pays a dividend yielding 0.78%, while Centene does not currently pay a regular dividend.

Are Centene and Labcorp in the same industry?

Yes. Both are classified in the Medical Specialities industry within the Health Care sector.

More comparisons